WAG Related Analyst Comments
-
Leerink Swann Upgrades AmerisourceBergen (ABC) to Outperform
-
Walgreen (WAG) / Alliance Boots Synergies Tracking In-Line
-
AmerisourceBergen (ABC) Likely to Score Another Win Against McKesson (MCK)
-
AmerisourceBergen (ABC) Not Fully Reflecting Walgreens Deal - Goldman Sachs
-
Express Scripts (ESRX) Pricing Aggressively, Leerink Swann Maintains Buy
-
Cardinal Health (CAH) Needs CVS Renewal After Walgreen Loss - Analyst
-
Goldman Sachs Downgrades Walgreen (WAG) to Buy, Less Upside Potential
-
With Walgreen (WAG) Deal in Bag, AmerisourceBergen (ABC) Could Be Takeout Target
-
Goldman Sachs Downgrades CVS Caremark (CVS) to Neutral, Few Catalysts
-
Goldman Lauds RadioShack's (RSH) New CEO Choice; Still Sees Challenges Ahead
-
Walgreen (WAG) Comps Make Strong Gains in January; May Signal Rebound
-
Cantor Fitzgerald's Conviction Calls For 2013
-
Goldman Sachs Lifts PT on Walgreen (WAG), Maintains Top Rating Post Q1 Noise
-
Christmas Comes Early For For Walgreen (WAG) Bulls
-
CVS (CVS) Taking Walgreen (WAG) Share - Analyst
-
Jefferies Cuts PT on Green Dot (GDOT), Sees Another Large Client May Move to AmEx (AXP)
-
Wal-Mart (WMT) Friendly Neighborhood Stores Have Sinister Plans for Competitor Walgreens (WAG)
-
Leerink Swann on Pharmacy Benefit Managers: TRICARE Excludes Walgreen (WAG) from Network, Positive for Express Scripts (ESRX)
-
Jefferies Maintains a 'Hold' on Walgreen (WAG); Goodbye TRICARE
-
Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); On Track With Narrow Network Strategy
-
Jefferies Maintains a 'Hold' on Walgreen (WAG); Key Takeaways From NYC Meeting w/ Mgmt
-
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); OraQuick HIV-OTC Test in 30,000 Locations
-
Goldman Sachs Maintains a 'Neutral' on Rite-Aid (RAD); Same-Store Sales Reflect Impact of Generics
-
Morgan Stanley Says Express Scripts (ESRX) Customers Becoming Cozy with Rite Aid (RAD)
-
UBS Reiterates a 'Neutral' on Rite-Aid (RAD); A Few Longer-Term Tailwinds, But Staying Sidelined For Now
-
UBS Maintains a 'Buy' on Cardinal Health (CAH); Color on Safeway Contract
-
UBS Raises Numbers on CVS Caremark (CVS); Comments From Conference Call
-
UBS Maintains a 'Buy' on Walgreen (WAG); Downside Risk Priced In, Creating Favorable Risk/Reward Balance
-
Analyst Calls Bid for Rite Aid (RAD) by Walgreen (WAG) 'Highly Unlikely'
-
Analyst Thinks Walgreen (WAG) Acquiring Rite Aid (RAD) 'Makes Sense'
-
Jefferies Maintains a 'Buy' on Express Scripts (ESRX); Incurs High Q4 Expenses As Its Preps For MHS Integration
-
Jefferies Maintains a 'Buy' on CVS Caremark (CVS); A Superior Model
-
UBS Maintains a 'Buy' on CVS Caremark (CVS); Raising FY12/13 EPS Estimates
-
UBS Maintains a 'Neutral' on Rite-Aid (RAD); Expect Accelerated EBITDA in Calendar ‘12
-
UBS Maintains a 'Buy' on Walgreen (WAG); January Comps Will Represent First Month Without ESRX
-
UBS Maintains a 'Buy' on Express Scripts (ESRX); Raising Estimates for Medco Merger
-
UBS Maintains a 'Neutral' on CVS Caremark (CVS); Raising ‘13 EPS for Generics/PBM Mojo
-
Jefferies Cuts Price Targets on Walgreen (WAG), Sees 'Subdued Performance' in 2012
-
Deutsche Cuts Price Target on Walgreen (WAG) Following Quarterly Miss
-
Barclays Maintains an 'Overweight' on Express Scripts (ESRX); Supply Chain Exec Dismissal to Alter WAG Settlement Chances?
-
Barclays maintains an 'Underweight' on Walgreen (WAG); 1Q12 Earnings Preview
-
Barclays Maintains an 'Underweight' on Walgreen (WAG); November Sales Preview
-
UBS Maintains a 'Buy' on CVS Caremark (CVS); Post-Call: Plenty of Positive Datapoints
-
Jefferies Raises Price Target on CVS Caremark (CVS), Sees Upside Potential
-
Citi Says Buy CVS (CVS) Ahead of Q3 Results as Walgreen/Express Scripts Talks Ongoing
-
UBS Maintains a 'Buy' on Walgreen (WAG); Lowering EPS Estimates; Still Assume ESRX Resolution in Published Estimates
-
Barclays Maintains an 'Underweight' on Walgreen (WAG); September Sales Preview
-
Barclays on Retail: 2011 Holiday Outlook: Ho Hum, Not Ho Ho
-
Barclays Maintains an 'Underweight' on Walgreen (WAG); Current Earnings Don't Matter
-
Jefferies Cuts Price Target on Walgreen (WAG), Encourges a Settlement with Express Scripts (ESRX)
Back to WAG Stock Lookup
